SHSujeong Han

Sujeong Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sujeong Han has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Herbarium specimens in the age of artificial intelligence: from herbarium image identification to Integrative Taxonomic AI

    by Atsuko Takano, Hyeonji Moon, Masato Shirai, Shuichiro Tagane, Diego Tavares Vasques, Chung-Kun Lee, Amjad Khan, Jeongwoo Seo, Sujeong Han, Chanho Park, et al.

    Herbarium specimens are physical, verifiable records that form the basis of taxonomic knowledge and biodiversity research. Their large-scale digitization has produced extensive collections of high-resolution images and associated specimen metadata, creating conditions in which artificial intelligence (AI) can play an important role in plant taxonomy, collection management, and ecological research. Early AI applications have primarily focused on automated species identification based on individual specimen images. Although increasingly accurate, such approaches remain limited by their emphasis on single-specimen label prediction and by treating identification outputs as final analytical decisions. Recent methodological advances—including segmentation-based preprocessing, automated trait extraction, structured extraction of label data, detection of potentially misidentified specimens, and multimodal integration of visual, textual, and genetic information—extend AI applications beyond species identification toward broader analytical frameworks, encompassing taxonomic interpretation as well as ecological and biodiversity research. In these approaches, specimens are placed within a shared analytical space, and identification results are used to support comparisons across multiple specimens rather than being treated as final decisions for single individuals. This multi-specimen perspective enables quantitative examination of species boundaries, morphological variation, data inconsistencies, and taxonomic stability within curated collections. In this context, AI serves not as an ultimate decision-maker but as a decision-support tool embedded in expert-guided workflows and biodiversity knowledge infrastructures. These developments can be summarized as Integrative Taxonomic AI , an approach that employs learned morphospaces to interpret and refine taxonomic categories by integrating multimodal evidence and curated specimen data under expert guidance.

  • Open Access

    Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma

    by Sang Eun Yoon, Woorim Kang, Junhun Cho, Hyeon Ji Cho, Mauricio Chalita, Hyun-Seok Oh, Dong-Wook Hyun, Sujeong Han, Hyun Kim, Hojun Sung, et al.

    CD19 chimeric antigen receptor (CAR) T-cell therapy has revolutionized treatment for relapsed/refractory diffuse large B-cell lymphoma (R/R-DLBCL), but challenges such as posttreatment failure and immune-related adverse events (AEs) persist. This study explores the gut microbiome as a predictive biomarker for CAR T-cell therapy outcomes and toxicity. Stool and serum samples from patients with R/R-DLBCL were analyzed at apheresis (47 samples) and 1 month after infusion (32 samples) using whole-genome sequencing metagenomics. When compared with healthy controls and newly-diagnosed DLBCL, R/R-DLBCL showed significant gut dysbiosis, characterized by increased Proteobacteria and Enterobacteriaceae. Responders had higher levels of Bacteroides fragilis, whereas nonresponders exhibited higher levels of Faecalibacterium prausnitzii. Functional metagenomic analysis suggested enrichment of inosine biosynthesis pathways in responders, and elevated serum inosine demonstrated an exploratory association with improved progression-free survival. Distinct microbial taxa and serum fatty acid profiles were also linked to CAR T-cell–related AEs, with higher acetate and butyrate levels in patients without AEs and increased isovalerate in those with AEs. These findings indicate that gut microbiome features—particularly Bacteroides fragilis and inosine metabolism—may serve as candidate biomarkers for CAR T-cell therapy outcomes and toxicity. However, given the exploratory nature of these analyses and the limited cohort size, results should be interpreted cautiously. Larger, prospective studies will be required to validate these observations and to assess the potential of microbiome-based strategies to optimize CAR T-cell therapy in R/R-DLBCL.


  • A survey of neural network segmentation and validation on plant specimen images of Korean Violaceae

    by Sujeong Han, Hyeonji Moon, Sanghyuck Lee, A-Seong Moon, Min-Kyung Sung, Jeongwon Lee, Sangtae Kim, Jaesung Lee